Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. Food and Drug Administration 510 (k) clearance for its Philips SmartCT ...
Azurion is Philips' next generation image-guided therapy platform and the new core of its integrated solutions portfolio. Azurion supports a full range of configurations across a broad spectrum of ...
New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, ...
New level of integration across imaging, physiology, hemodynamic and informatics applications SmartCT guides acquisition of 3D CT-like images and provides visualization and measurement tools Increased ...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. Food and Drug Administration 510 (k) clearance for its Philips SmartCT application software. SmartCT is ...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its next-generation Philips Azurion image-guided therapy platform, marking an important step forward in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback